Intensive Lipid-Lowering With Atorvastatin for Secondary Prevention in Patients After Coronary Artery Bypass Surgery
Authors:
- David D. WatersDWDavid D. Waters
- Philip BarterPBPhilip Barter
- John J.P. KasteleinJKJohn J.P. Kastelein
- James ShepherdJSJames Shepherd
- Nanette K. WengerNWNanette K. Wenger
- David A. DeMiccoDDDavid A. DeMicco
- Andrei BreaznaABAndrei Breazna
- John C. LaRosaJLJohn C. LaRosa
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- High-Dose Atorvastatin after Stroke or Transient Ischemic AttackNew England Journal of Medicine, 2006
- Comparative Safety of Atorvastatin 80 mg Versus 10 mg Derived from Analysis of 49 Completed Trials in 14,236 PatientsThe American Journal of Cardiology, 2006
- Intensive Lipid Lowering with Atorvastatin in Patients with Stable Coronary DiseaseNew England Journal of Medicine, 2005
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?The American Journal of Cardiology, 2004
- Care after Coronary-Artery Bypass SurgeryNew England Journal of Medicine, 2003
- Prognostic factors for atherosclerosis progression in saphenous vein graftsJACC, 2000
- Long-Term Effects on Clinical Outcomes of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation in the Post Coronary Artery Bypass Graft TrialCirculation, 2000
- Pravastatin prevents clinical events in revascularized patients with average cholesterol concentrationsJACC, 1999
- The Effect of Aggressive Lowering of Low-Density Lipoprotein Cholesterol Levels and Low-Dose Anticoagulation on Obstructive Changes in Saphenous-Vein Coronary-Artery Bypass GraftsNew England Journal of Medicine, 1997